(Q30377937)

21 June 2017

A prime-boost vaccination of mice with heterologous H5N1 strains. (English)

1 reference

21 June 2017

6

Takato Odagiri

1 reference

21 June 2017

Daisuke Ikeno

1

1 reference

21 June 2017

Kazuhiko Kimachi

2

1 reference

21 June 2017

Yasuhiro Kudo

3

1 reference

21 June 2017

Shuro Goto

4

1 reference

21 June 2017

Shigeyuki Itamura

5

1 reference

21 June 2017

Masato Tashiro

7

1 reference

21 June 2017

Yoichiro Kino

8

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

21 June 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 June 2017

27

1 reference

21 June 2017

23

1 reference

21 June 2017

3121-3125

1 reference

Probable person-to-person transmission of avian influenza A (H5N1)

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Avian influenza. Human transmission but no pandemic in Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Summary of Clinical Trials of Influenza Virus Vaccines in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Pre- or post-pandemic influenza vaccine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Developing vaccines against pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

Immunological concepts of vaccine adjuvant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.007

10.1016/J.VACCINE.2009.01.007

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference